Introduction
Knee osteoarthritis (OA) is a common condition in which prevalence increases with age. Management includes pharmacological treatment, i.e., nonsteroid inflammatory drugs (NSAIDs), analgesics, intraarticular injections of corticosteroids or other compounds, symptomatic slow acting drugs, and surgery, such as osteotomy and arthroplasty [1] [2] [3] . Nonpharmacological and nonsurgical management, such as patient education, physical therapy, weight management in overweight patients, and orthoses and assistive devices 1-3 are strongly recommended.
Some factors suggest that laterally elevated wedged insoles might be useful in the treatment of medial femorotibial knee OA. The biomechanical effects of laterally wedged insoles on knee OA have been evaluated. The mechanical axis of the lower limb approaches a more upright position, with decreased loading on the medial compartment of the knee joint and the tensile force of the lateral side 4 . Moreover, the lateral thrust at the knee after heel strike is reduced with the use of valgus insoles 5 . The potential clinical benefit of such insoles can be to improve symptoms in painful knee OA patients, to prevent long-term structural deterioration, or both. To our knowledge, the structural effect of such treatment has never been evaluated. The symptomatic effect has been evaluated in various studies, all concluding that there is a short-term beneficial effect [5] [6] [7] . However, all these studies were of open design, and hence the improvement observed might be due to the treatment, to the natural history of the disease, and/or to a placebo effect.
To address this question, a prospective randomized controlled study, comparing the symptomatic effects of laterally wedged insoles and neutrally wedged insoles (used as control), in patients with medial femoro-tibial knee OA, was undertaken.
Material and methods

STUDY DESIGN
This multicenter (three centers), prospective randomized controlled study was conducted in order to compare the effects of laterally elevated (valgus) and neutrally wedged insoles (control), in patients with medial compartment femoro-tibial knee OA. The study protocol was approved by the local ethics committee (Hô pital Cochin, Paris, France).
INCLUSION AND EXCLUSION CRITERIA
Outpatients visiting a rheumatologist and fulfilling the American College of Rheumatology criteria for knee OA 8 were enrolled in the study, after written informed consent was obtained. The patients were told that the study aimed to compare two kinds of insoles, but not that one was presumed to be of greater efficacy than the other. This is not a full informed consent, but this approach was considered by the investigators as ethical since it as been suggested that neutrally wedged insoles might relieve some symptoms through absorbing impact loading 2 . Moreover, this approach was approved by the Ethical Review Board member. Other inclusion criteria were age 18 or older, pain on a daily basis for at least 1 month during the last 3 months, pain of at least 30 (100 visual analog scale) after physical activities during the previous 2 days, predominance of pain in the medial part of the knee (this information was obtained by interviewing the patients), evidence of medial femorotibial OA on plain anteroposterior X-rays (Kellgren and Lawrence stage ≥2).
Exclusion criteria were functional class of IV (Steinbrocker), greater or similar reduction in lateral than medial femorotibial joint space width on plain anteroposterior X-rays, secondary knee OA 9 , hip OA, hallux rigidus, valgus deformity of the midfoot, other symptomatic deformity of the foot, advanced arthropathy of the hindfoot, any disease treated with insoles within the past 6 months, previous ankle arthrodesis, tibial osteotomy within the previous 5 years, knee joint lavage within the previous 3 months, intraarticular corticosteroid injection within the previous month, changes in drug treatment for OA within the previous week.
STUDY COURSE
Each patient was recruited by a rheumatologist (one in each center). The chiropodist (PK) then confirmed the inclusion and randomized the patient. Symptomatic efficacy was evaluated using standardized questionnaires mailed to the patient. Any missing data were collected from the patient by a research nurse, unaware of the randomization, by telephone. Tolerability and compliance were also evaluated using standardized questionnaires mailed to the patient. The amount of concomitant treatment required by the patient was obtained by the research nurse through a telephone conservation with the patient. Follow-up evaluations were made at months 1, 3, and 6. During the follow-up, the patients were treated either by their general practitioner or their rheumatologist, who indicated any concomitant therapy (analgesics, NSAIDs, intraarticular injection, etc.).
BASELINE EVALUATION
Age, gender, body mass index, Steinbrocker functional class, pain, past history of knee OA and treatment were noted.
An anteroposterior weight-bearing standing radiograph of the knee joints (tube to film distance 100 cm, X-ray beam centered on joint space and inclined parallel to the tibial plateau, joint fully extended), and a radiograph of the femoropatellar joints were made. The Kellgren and Lawrence (KL) grade 10 and the joint space width (using a clear plastic ruler graduated in half millimeters) of the medial femorotibial joint were determined. The presence of OA in homolateral femoropatellar and/or lateral femorotibial joints and in contralateral femoropatellar and/or femorotibial joints was noted.
OUTCOME MEASURES
The patient's overall assessment of disease activity during the previous 2 days (0-4 grade scale; none, mild, moderate, severe, very severe), the Western Ontario and McMaster Universities (WOMAC) index 11 , were obtained at baseline and at months 1, 3, and 6. At baseline and at the end of the 6 months of the study, the patients were asked how many days during the previous 3 months he/she needed concomitant treatment (analgesics, NSAIDs) because of a painful condition related to his/her knee OA.
Compliance and tolerance were evaluated at months 3 and 6. The patients were asked whether they wore continuously, intermittently, or did not wear insoles. Additionally, they evaluated tolerance on a 5-grade scale (no discomfort, mild, moderate, severe, very severe discomfort). TREATMENT Patients were randomly assigned to one of two groups: bilateral laterally elevated (valgus) and bilateral neutrally wedged insoles ( Fig. 1 ). Insoles were made of Ledos material (Socié té Française d'Orthopodie, Paris, France), mounted on a leather strip. The Ledos material is made of pure rubber with cork powder, and has a great capacity to absorb impact loading. The laterally elevated insoles were individually modeled, with elevation depending on static pedometer evaluation, but without any biomechanical evaluation during walking.
STATISTICAL ANALYSIS
Analysis was made using an intention-to-treat approach. The main criterion for assessment of efficacy was chosen prior to the study and defined as an improvement in the patient's overall assessment of disease activity at month 6 compared with baseline. Improvement was defined as a reduction of 1 grade or more from baseline, and no corticosteroid or hyaluronate intraarticular injection or articular lavage during the follow-up. The presence or not of improvement was compared between the two groups using Fisher's exact test.
A difference of 20% between the two groups in the percentages of patients with an improvement in the patient's overall assessment was considered as clinically relevant. A sample size of 70 patients for each group was required to detect such a 20% difference, with a significance level of 95% and a power of 80%.
The baseline characteristics of patients were compared between the groups with and without an improvement in the patient's overall assessment of disease activity at month 6, using Fisher's exact test, the Chi-2 test, and ANOVA (after homogeneity of variances was checked using Levene's test). The evaluated variables were as follows: age, gender, body mass index, Steinbrocker functional class, pain, patient's overall assessment of disease activity, WOMAC subscales, Kellgren and Lawrence radiographic stage, joint space width, presence of a homolateral femoropatellar OA, a homolateral lateral femorotibial OA, a contralateral femoropatellar, medial and lateral femorotibial OA, mean analgesics and NSAIDs intake during the previous 3 months, treatment with 'disease modifying drugs' (yes or no). A multivariate analysis was then performed. The dependent variable was the presence or not of an improvement in the patient's assessment of disease activity. The independent variables were the insole group, and the variables which were related with a P value less than 0.05 to the presence or not of an improvement on univariate analysis.
As a secondary analysis, improvement or not in the patient's overall assessment of disease activity at months 1 and 3, compared to baseline, were compared between the two groups using Fisher's exact test. In addition, improvement or not in the WOMAC index subscales at months 1, 3 and 6 was compared between the two groups using Fisher's exact test. Improvement in the WOMAC index subscales was defined as a decrease of ≥30% compared with baseline, and no corticosteroid or hyaluronate intraarticular injections, or joint lavage during the follow-up.
The other secondary outcome measure was evaluation of concomitant therapies. The need for intraarticular injection or joint lavage during the follow-up was compared between the two treatment groups using Fisher's exact test. The number of days with analgesics and NSAIDs intake during the previous 3 months were compared with baseline using Wilcoxon's paired-test.
Finally, compliance at months 3 and 6 was evaluated and compared between the groups using the Chi-square test.
Results
One hundred and fifty six patients (41 males, 115 females, mean age 64.8 years±10.4 S.D.) were included. Figure 2 summarizes the study course. After randomization, patients were assigned to neutrally wedged or to laterally wedged insoles (74 and 82 patients respectively). The baseline characteristics of patients are shown in Table  I . One patient was lost to follow-up after the 1-month, and one after the 3 month evaluations. Sudden death occurred in two patients after the 3-month evaluation. One patient underwent total arthroplasty of the evaluated knee after the 3-month visit. Four patients decided to withdraw from the study after the 3-month evaluation due to intolerance (one patient), inefficacy (two patients), personal reasons (one patient). In all these patients, the results of the last evaluation were taken into account as final results.
The patient's overall assessments of disease activity are shown in Table II . At month 6 the assessment was improved in 44 patients, seven of whom received intraarticular injection or articular lavage during the follow-up. Consequently, the patient's assessment was considered as improved in 37 patients, including 17/74 patients (23%) in the neutrally wedged insole group and in 20/82 patients (24%) in the laterally wedged insole group (P=0.85). Similar results were obtained at months 1 and 3. At month 1, the assessment was considered improved in 19 patients (26%) in the neutrally wedged insole group and in 18 patients (22%) in the laterally wedged insole group (P=0.71). At month 3 the assessment was considered improved in 18 patients (24%) in the neutrally wedged insole group and in 20 patients (24%) in the laterally wedged insole group (P=1).
The only variable related to the presence or not of an improvement of the patient's overall assessment of disease activity at month 6 was the baseline patient's assessment of disease activity (P<0.001). The greater the baseline assessment, the higher the percentage of improved patients: an improvement was observed in none of the eight patients (0%), 11 of the 76 patients (15%), 23 of the 66 patients (35%), and three of the six patients (50%) with a baseline overall assessment of I, II, III and IV, respectively. On multivariate analysis, the baseline patient's assessment of disease activity was again related to the presence of an improvement (P=0.001), but the insole group was not (P=0.9).
The WOMAC index scores are shown in Table II . At month 6, the WOMAC pain subscale was improved in 16/74 patients (22%) and in 16/82 patients (20%) in the neutrally and the laterally wedged insole groups, respectively (P=0.84). The WOMAC joint stiffness subscale was improved in 19 (26%) and in 16 patients (20%) in the neutrally and the laterally wedged insole groups, respectively (P=0.44). The WOMAC physical functioning subscale was improved in 10 patients (14%) and in 10 patients (12%) in the neutrally and the laterally wedged insole groups, respectively (P=0.82). Similar results were obtained at months 1 and 3.
Twenty-two patients were treated with corticosteroids (13 patients) or hyaluronate (six patients), intraarticular injections, or articular lavage (three patients) during the follow-up. Among these, 13 were in the neutrally wedged insole group and nine in the laterally wedged insole group (P=0.26).
The need for concomitant treatment during the study is shown in Table III . At baseline, there was no difference between the two groups. At month 6, there was a statistically significant reduction in NSAIDs intake and a trend toward a reduction in analgesic intake in the laterallywedged insole group, while in the other group the consumption of analgesics and NSAIDs remained unchanged, suggesting a symptomatic drug-sparring effect of the laterally wedged insoles.
Compliance and tolerance were satisfactory. At endpoint, 127 patients wore insoles permanently, 16 intermittently, and eight no longer wore insoles (data missing for five Osteoarthritis and Cartilage Vol. 9, No. 8 patients), while at month 3, 130 patients wore insoles permanently, 17 intermittently, and three no longer wore insoles (data missing for six patients) (Table IV) . At endpoint, there was a statistically significant difference between the two groups in terms of compliance (P=0.032), with in particular a greater frequency of patients who wore insoles permanently in the laterally wedged insole group than in the other group (88% vs 74%). At month 3, compliance did not differ statistically between the groups (P=0.12). At month 6, the reasons for no longer wearing insoles were intolerance (one patient in the treated group, two in the control group), inefficacy (two patients in the treated group, one in the control group), others (one patient in each group), and those for wearing insoles intermittently were intolerance (three patients in the control group) and inefficacy (three patients in the treated group, eight in the control group) (two missing data).
Discussion
This study failed to demonstrate a relevant short-term symptomatic effect of laterally-wedged insoles in medial femoro-tibial OA. However, the decrease in NSAIDs consumption in the treated group is in favor of a beneficial effect of laterally-wedged insoles in the management of peripheral medial femoro-tibial knee OA patients.
This apparent lack of effect is in contradiction with several previous studies suggesting effectiveness of laterally wedged insoles in patients with medial knee OA [5] [6] [7] . Three main hypotheses can be put forward to explain this discrepancy: laterally wedged insoles are effective, but this study failed to demonstrate it; laterally wedged insoles are ineffective; laterally wedged insoles are effective in some subgroups of patients rather than in the whole population.
For the hypothesis that laterally wedged insoles are effective but that this study failed to demonstrate it, several explanations are possible: the control group not being a real placebo group, concomitant therapies, compliance, duration of follow-up, degree of wedging of the lateral insoles.
First, the control group was not a real placebo group, since patients wore neutrally wedged insoles that might have relieved some symptoms through absorbing impact loading 2 . Unfortunately, it was difficult to proceed differently in the context of a prospective controlled study.
Second, during the follow-up, the patients' usual practitioners were allowed to change systemic OA therapies, and intraarticular corticosteroid or hyaluronate injections and joint lavage were allowed. Although the occurrence of intraarticular injections and joint lavage were taken into account in the analysis, they might have modified the results. The patients used analgesics and NSAIDs when necessary. Some improved patients might have decreased the doses of these drugs, resulting in less improvement. Although a more objective assessment of concomitant medication than the self-reported NSAIDs and analgesic intake (on a rather long period of usage) might have been employed, and although a correction for multiple assessment was not included in the statistical analysis, the results concerning NSAIDs consumption are in favor of this hypothesis, since there was at month 6 a statistically significant and a clinically meaningful (−29.8%) reduction in NSAIDs intake in the laterally wedged insole group. The disadvantages of allowing changes in OA treatments during the follow-up were known at the time of design of the study, but in long term studies, it is neither ethical nor practical to exclude all concomitant treatments [9] [10] [11] [12] . However, we recognize that permitting changes in OA treatment is a caveat and, although difficult, it might be preferable to allow no new intervention during the follow-up in such studies.
The better compliance at month 6 observed in the laterally-wedged insole group might also be considered as an indirect argument in favor of better efficacy of these insoles. However, compliance could be related to foot comfort and factors other than amelioration of knee OA symptoms. Unfortunately, the high proportion of patients wearing insoles permanently did not allow us to compare between the groups with regard to the reasons for wearing insoles intermittently and no longer wearing insoles. Third, since symptoms and functional impairment can vary with time in knee OA, and since the disease usually progresses slowly 1 , the 6-month evaluation was possibly premature.
Finally, the laterally-wedged insoles might have been designed in an incorrect degree of wedging. In particular, the individual modeling might have been performed according to biomechanic evaluation during walking, rather than according to static pedometer evaluation.
In the second hypothesis, laterally wedged insoles would be ineffective in patients with medial knee OA. The symptomatic effects have been evaluated in different studies, all concluding to a short-term beneficial effect [5] [6] [7] ; however, none of these previous studies was prospective, randomized and controlled. The first was a comparative study (indomethacine vs indomethacine+insoles). One group comprised patients followed by one of the authors, and the second group by patients followed by the other 6 . Consequently, no randomization was performed, and neither the practitioner nor the patient was blinded for treatment groups. Moreover, the analysis was not performed using an intention to treat approach. Another study was open, with no control groups 7 . Finally, the main objective of the study by Ogata et al. was to evaluate the biomechanical effects of wedged insoles on the osteoarthritic knee, rather than clinical efficacy; thus the study was not double-blind randomized, and some methodological information is lacking 5 . Hence the discrepancy between results of our double-blind randomized study and those of previous studies might be due to different designs, with more convincing results from the double-blind randomized study. In this study, the lack of significant difference between groups in the primary and in most secondary outcomes does not support the use of laterally-wedged insoles in medial knee OA. Moreover, the results given in Table II might suggest that the neutral group had a better response in terms of WOMAC. For example, pain fell from 53.5 to 52.8 in the lateral-wedged group and from 52 to 46.4 in the neutral wedged group. The interpretation of such results is difficult and might be only related to chance. We would like to emphasize that there was no statistically significant difference between the two groups concerning these variables and that the expression of the results in terms of responders does not support a better symptomatic effect of neutral insoles when compared to the laterally elevated ones.
In this study, patient's overall assessment was a priori chosen as the main assessment criterion. This variable is one of the three included in the core set recommended by OMERACT 13 . However, the OARSI society 14 suggests that pain, obtained using VAS, Likert scale, or WOMAC pain subscale, should be used as primary outcome. In this study, using the WOMAC pain subscale as primary outcome would not have change the results or the conclusion.
Finally, there were no arguments to support the hypothesis that laterally wedged insoles are effective in some subgroups of patients rather than in the whole population. Particularly, although it has been suggested that laterally wedged insoles are more effective in patients with mild or moderate than in those with advanced structural involvement 5, 6 , there was no significant correlation between the presence of an improvement in the patient's overall assessment and the baseline Kellgren and Lawrence radiographic stage or joint space width. Moreover, one could suppose that laterally wedged insoles might be more effective in patients with isolated medial femorotibial OA than in those with medial femorotibial OA associated with another knee compartment OA. However, an associated femoropatellar or lateral femorotibial OA were found not to affect the results. The only variable that was related to the presence of an improvement in the patient's overall assessment was baseline overall assessment. However, the multivariate analysis suggested that this result did not depend on treatment groups, so it might be only due to the timevariation of symptoms in knee OA. Laterally wedged insoles were well tolerated by patients with medial knee OA. Despite the lack of significant difference between groups in the primary and in most secondary outcomes, the reduction in NSAIDs consumption might be considered as indirect support for some efficacy of the laterally wedged insoles. Other studies on other sets of patients would be of interest to confirm these results. The structural effect of laterally wedged insoles in medial knee OA should be also evaluated.
